Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum β-lactamase production in Enterobacter spp.

被引:12
作者
Schwaber, MJ
Navon-Venezia, S
Chmelnitsky, I
Leavitt, A
Schwartz, D
Carmeli, Y
机构
[1] Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, IL-64239 Tel Aviv, Israel
关键词
D O I
10.1128/JCM.44.1.241-243.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Forty clinical isolates of Enterobacter spp. were identified as extended-spectrum P-lactamase (ESBL) producers by disk diffusion. The VITEK 2 Advanced Expert System (AES) identified the ESBL phenotype in only 25 isolates (62.5%), and erroneously reported cephalosporin susceptibility in 11 isolates (28%). Refinements in the AES are required in order to improve ESBL detection in Enterobacter.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 17 条
  • [11] Potential impact of the VITEK 2 system and the advanced expert system on the clinical laboratory of a university-based hospital
    Sanders, CC
    Peyret, M
    Moland, ES
    Cavalieri, SJ
    Shubert, C
    Thomson, KS
    Boeufgras, JM
    Sanders, WE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) : 2379 - 2385
  • [12] Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel
    Schlesinger, J
    Navon-Venezia, S
    Chmelnitskv, I
    Hammer-Münz, O
    Leavitt, A
    Gold, HS
    Schwaber, MJ
    Carmeli, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1150 - 1156
  • [13] Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae
    Schwaber, MJ
    Raney, PM
    Rasheed, JK
    Biddle, JW
    Williams, P
    McGowan, JE
    Tenover, FC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) : 294 - 298
  • [14] Acceptable performance of VITEK 2 system to detect extended-spectrum β-lactamases in clinical isolates of Escherichia coli:: a comparative study of phenotypic commercial methods and NCCLS guidelines
    Sorlózano, A
    Gutiérrez, J
    Piédrola, G
    Soto, MJ
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (03) : 191 - 193
  • [15] Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates
    Stürenburg, E
    Sobottka, I
    Feucht, HH
    Mack, D
    Laufs, R
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (01) : 29 - 34
  • [16] Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection
    Stürenburg, E
    Sobottka, I
    Noor, D
    Laufs, R
    Mack, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) : 134 - 138
  • [17] Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes
    Tzelepi, E
    Giakkoupi, P
    Sofianou, D
    Loukova, V
    Kemeroglou, A
    Tsakris, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 542 - 546